سعر سوابيلول 25مجم/5مل 20 جرعة موحدة 5مل 2024

Atenolol oral solution in pre-measured single-dose 5 ml units (20 per pack) made by Uniswab, Egypt, for patients who have difficulty swallowing tablets.

• Management of hypertensionPopulation: Adultselectronic medicines compendium (eMC), UK
• Management of anginaPopulation: Adultselectronic medicines compendium (eMC), UK
• Management of cardiac arrhythmiasPopulation: Adultselectronic medicines compendium (eMC), UK

• Common: bradycardia, cold extremities, gastrointestinal disturbance, fatigue. Rare: heart block, worsening heart failure, dizziness, sleep disturbance, bronchospasm in asthmatics, rash, thrombocytopenia.General active-ingredient information · electronic medicines compendium (eMC), UK

• Contraindicated in cardiogenic shock, uncontrolled heart failure, sick sinus syndrome, second- or third-degree heart block, untreated phaeochromocytoma, metabolic acidosis, bradycardia (<45 bpm), hypotension, severe peripheral arterial circulatory disturbances and hypersensitivity.General active-ingredient information · electronic medicines compendium (eMC), UK

• Do not withdraw abruptly; taper over 7-14 days, especially in ischaemic heart disease.General active-ingredient information · electronic medicines compendium (eMC), UK
• Avoid in reversible obstructive airways disease unless compelling reasons; use with caution.General active-ingredient information · electronic medicines compendium (eMC), UK
• May mask symptoms of hypoglycaemia (tachycardia) and signs of thyrotoxicosis.General active-ingredient information · electronic medicines compendium (eMC), UK

• Verapamil, diltiazemExaggerated negative inotropic/conduction effects: severe hypotension, bradycardia, heart failure; avoid IV use of either within 48 h of stopping the other.electronic medicines compendium (eMC), UK
• ClonidineBeta-blockers may exacerbate rebound hypertension after clonidine withdrawal; stop the beta-blocker several days before clonidine.electronic medicines compendium (eMC), UK
• Insulin and oral antidiabeticsEnhanced glucose-lowering effect; hypoglycaemia symptoms (tachycardia) may be masked.electronic medicines compendium (eMC), UK

• Atenolol crosses the placenta; use in pregnancy has been associated with intra-uterine growth retardation; benefit must outweigh risk, particularly in the first and second trimesters.General active-ingredient information · electronic medicines compendium (eMC), UK
• Significant accumulation in breast milk; breast-fed neonates may be at risk of hypoglycaemia and bradycardia; use with caution.General active-ingredient information · electronic medicines compendium (eMC), UK

• Atenolol: Beta1-selective beta-adrenergic receptor blocker without membrane-stabilizing or intrinsic sympathomimetic activity; selectivity is not absolute and higher doses also inhibit beta2 receptors (US label).